Use of rocuronium and sugammadex under neuromuscular transmission monitoring in a patient with multiple sclerosis
Multiple sclerosis (MS) is a potentially disabling disease characterized by demyelinating lesions in the central nervous system. One of the anesthetic challenges encountered in surgical patients with MS is the management of neuromuscular blockade (NMB) and its reversal. We report a case of a 31-year...
Main Authors: | Chryssoula Staikou, Martina Rekatsina |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Saudi Journal of Anaesthesia |
Subjects: | |
Online Access: | http://www.saudija.org/article.asp?issn=1658-354X;year=2017;volume=11;issue=4;spage=472;epage=475;aulast=Staikou |
Similar Items
-
Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade
by: Kyo Sang Kim, et al.
Published: (2016-06-01) -
Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
by: Marie T. Aouad, et al.
Published: (2017-04-01) -
Chronic exposure to dexamethasone may not affect sugammadex reversal of rocuronium-induced neuromuscular blockade: an in vivo study on rats
by: Ha Yeon Park, et al.
Published: (2023-07-01) -
Impact on grafted kidney function of rocuronium-sugammadex vs cisatracurium-neostigmine strategy for neuromuscular block management. An Italian single-center, 2014-2017 retrospective cohort case-control study
by: M. Carron, et al.
Published: (2022-01-01) -
Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
by: Tiffany Woo, et al.
Published: (2013-12-01)